UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Flu vaccine VaxigripTetra fit for upcoming flu season’
Sanofi Pasteur Korea said its four-strain influenza vaccine VaxigripTetra, ...
by Nam Doo-hyun
|
2018-08-30 10:47
라인
‘Pharmaceutical stocks to bottom out soon’
Korean pharmaceutical and biotech shares are expected to have an upward tre...
by Nam Doo-hyun
|
2018-08-29 14:34
라인
Chong Kun Dang, Dongkook lead functional foods
Chong Kun Dang Healthcare, a subsidiary of Chong Kun Dang, topped the local...
by Nam Doo-hyun
|
2018-08-27 15:42
라인
‘Xeomin’s side effect lowest among 5 botulinum toxins’
Merz said its botulinum toxin product Xeomin showed the lowest level of ina...
by Nam Doo-hyun
|
2018-08-27 14:39
라인
Gilead’s Genvoya comfortably tops HIV treatments
Gilead Sciences Korea’s Genvoya has solidified its No. 1 status in the huma...
by Nam Doo-hyun
|
2018-08-24 14:33
라인
3 multinationals refuse to take pharma group’s anti-corruption system
GSK Korea, Janssen Korea and Astellas Pharma Korea refused to adopt ISO 370...
by Nam Doo-hyun
|
2018-08-23 12:01
라인
Foreign CEOs to lead Korean units of Novartis, Galderma
Novartis Korea and Galderma Korea will have new foreign CEOs next month.Nov...
by Nam Doo-hyun
|
2018-08-22 13:56
라인
[Special] Pharmaceuticals at odds with government over selective benefit system
The pharmaceutical industry is raising concerns over the government’s plan ...
by Nam Doo-hyun
|
2018-08-21 15:57
라인
Korea narrows gap with Japan in healthcare IoT patents
Korea is catching up with Japan in the Internet of Things (IoT) patents in ...
by Nam Doo-hyun
|
2018-08-16 15:52
라인
[Reporter’s Notebook] Is Korean market unimportant for Samsung Bioepis?
“Please insert ‘severe’ in front of ‘acute pancreatitis’ in the headline an...
by Nam Doo-hyun
|
2018-08-16 14:24
라인
Local patents increasingly target obesity
Amid forecasts that the obesity therapy market will rapidly grow, local res...
by Nam Doo-hyun
|
2018-08-14 16:26
라인
Who will be first to develop new acute pancreatitis remedy?
Korea’s Samsung Bioepis and Japan’s Takeda Pharmaceutical have teamed up to...
by Nam Doo-hyun
|
2018-08-14 10:32
라인
Bio stock slump drags down diagnostics, equipment, reagent companies
The shares of diagnostics, equipment, reagent and clinical agent companies ...
by Nam Doo-hyun
|
2018-08-09 14:29
라인
‘Bayer’s liver cancer drug better than expected’
Bayer Korea’s liver cancer therapy Stivarga (regorafenib) is expected to st...
by Nam Doo-hyun
|
2018-08-06 18:21
라인
2018-listed pharmaceutical, medical shares tank
With pharmaceutical and medical device stocks tumbling in Seoul, share pric...
by Nam Doo-hyun
|
2018-07-31 14:02
라인
Patent approved to predict chemotherapeutic effects for breast cancer patients
A new patent for predicting chemotherapeutic effects for patients with easi...
by Nam Doo-hyun
|
2018-07-27 11:50
라인
[Exclusive] Invossa patent expired in 6 European countries
Kolon Life Science has lost its substance patent for Invossa-K, a cell gene...
by Nam Doo-hyun
|
2018-07-26 11:16
라인
Which multinational drugmaker grew most rapidly in H1?
Daiichi Sankyo Korea achieved the most substantive sales growth among multi...
by Nam Doo-hyun
|
2018-07-25 11:52
라인
Will new patent help detect norovirus easily?
A new patent for checking antibody of norovirus is drawing attention, as th...
by Nam Doo-hyun
|
2018-07-05 17:24
라인
‘UCB Korea to keep pursuing patient value in neurology’
UCB Korea will undoubtedly lead the domestic epilepsy treatment market, its...
by Nam Doo-hyun
|
2018-07-04 14:37
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top